The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ASENSUS SURGICAL, INC. COM NEW 04367G103 1,658 510,142 SH   OTR   0 510,142 0
DECIPHERA PHARMACEUTICALS INC COM 24344T101 20,176 449,951 SH   OTR 1,2 0 449,951 0
X4 PHARMACEUTICALS INC COM 98420X103 2,682 311,490 SH   OTR 1,2 0 311,490 0
AVROBIO INC COM 05455M100 3,491 275,034 SH   OTR 1,2 0 275,034 0
SUTRO BIOPHARMA INC COM 869367102 41,527 1,824,542 SH   OTR   0 1,824,542 0
BICYCLE THERAPEUTICS PLC SPONSORED ADS 088786108 57,209 1,915,274 SH   OTR 1,2 0 1,915,274 0
MISONIX, INC. COM 604871103 33,186 1,694,017 SH   OTR 1,2 0 1,694,017 0
ADAPTHEALTH CORP. COM 00653Q102 107,033 2,911,677 SH   OTR 1,2 0 2,911,677 0